BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22272310)

  • 1. A MusD retrotransposon insertion in the mouse Slc6a5 gene causes alterations in neuromuscular junction maturation and behavioral phenotypes.
    Bogdanik LP; Chapman HD; Miers KE; Serreze DV; Burgess RW
    PLoS One; 2012; 7(1):e30217. PubMed ID: 22272310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
    Rousseau F; Aubrey KR; Supplisson S
    J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
    Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
    J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.
    Arribas-González E; de Juan-Sanz J; Aragón C; López-Corcuera B
    J Biol Chem; 2015 Jan; 290(4):2150-65. PubMed ID: 25480793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperekplexia-associated mutations in the neuronal glycine transporter 2.
    López-Corcuera B; Arribas-González E; Aragón C
    Neurochem Int; 2019 Feb; 123():95-100. PubMed ID: 29859229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Na+/K+-ATPase is a new interacting partner for the neuronal glycine transporter GlyT2 that downregulates its expression in vitro and in vivo.
    de Juan-Sanz J; Núñez E; Villarejo-López L; Pérez-Hernández D; Rodriguez-Fraticelli AE; López-Corcuera B; Vázquez J; Aragón C
    J Neurosci; 2013 Aug; 33(35):14269-81. PubMed ID: 23986260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic ablation of VIAAT in glycinergic neurons causes a severe respiratory phenotype and perinatal death.
    Rahman J; Besser S; Schnell C; Eulenburg V; Hirrlinger J; Wojcik SM; Hülsmann S
    Brain Struct Funct; 2015 Sep; 220(5):2835-49. PubMed ID: 25027639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
    de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B
    Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).
    de Juan-Sanz J; Núñez E; Zafra F; Berrocal M; Corbacho I; Ibáñez I; Arribas-González E; Marcos D; López-Corcuera B; Mata AM; Aragón C
    J Biol Chem; 2014 Dec; 289(49):34308-24. PubMed ID: 25315779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
    Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
    Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
    Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
    J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLRB is the third major gene of effect in hyperekplexia.
    Chung SK; Bode A; Cushion TD; Thomas RH; Hunt C; Wood SE; Pickrell WO; Drew CJ; Yamashita S; Shiang R; Leiz S; Longardt AC; Raile V; Weschke B; Puri RD; Verma IC; Harvey RJ; Ratnasinghe DD; Parker M; Rittey C; Masri A; Lingappa L; Howell OW; Vanbellinghen JF; Mullins JG; Lynch JW; Rees MI
    Hum Mol Genet; 2013 Mar; 22(5):927-40. PubMed ID: 23184146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
    de la Rocha-Muñoz A; Núñez E; Arribas-González E; López-Corcuera B; Aragón C; de Juan-Sanz J
    Sci Rep; 2019 Oct; 9(1):14944. PubMed ID: 31628376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
    de la Rocha-Muñoz A; Núñez E; Vishwanath AA; Gómez-López S; Dhanasobhon D; Rebola N; López-Corcuera B; de Juan-Sanz J; Aragón C
    Commun Biol; 2021 Oct; 4(1):1197. PubMed ID: 34663888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia.
    Eulenburg V; Becker K; Gomeza J; Schmitt B; Becker CM; Betz H
    Biochem Biophys Res Commun; 2006 Sep; 348(2):400-5. PubMed ID: 16884688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in
    Dafsari HS; Kawalia A; Sprute R; Karakaya M; Malenica A; Herkenrath P; Nürnberg P; Motameny S; Thiele H; Cirak S
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31604777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The postnatal development of ultrasonic vocalization-associated breathing is altered in glycine transporter 2-deficient mice.
    Hülsmann S; Oke Y; Mesuret G; Latal AT; Fortuna MG; Niebert M; Hirrlinger J; Fischer J; Hammerschmidt K
    J Physiol; 2019 Jan; 597(1):173-191. PubMed ID: 30296333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease.
    James VM; Gill JL; Topf M; Harvey RJ
    Biol Chem; 2012 Apr; 393(4):283-9. PubMed ID: 22114948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster.
    de Juan-Sanz J; Núñez E; López-Corcuera B; Aragón C
    PLoS One; 2013; 8(3):e58863. PubMed ID: 23484054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
    Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
    Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.